| Product description | Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard)/核酸扩增技术甲型肝炎病毒VL国际标准品 |
| Product number | 15/276 NIBSC15/276 |
| Category | Diagnostics Blood Borne Pathogens |
| Keywords | HAV, molecular |
| Type of standard | International Standard |
| Customer notes | Replaces 00/562 |
| Instructions for Use | 15-276.pdf Instructions for Use |
| Minimum quantity | 1 |
Hepatitis A Virus VL For Nucleic Acid Amplification Techniques UNITAGE This material has been assigned a unitage of 26300 IU/mL (~4.42 log10 IU/mL) when reconstituted in 0.5 mL of nuclease-free water. Uncertainty: the assigned unitage does not carry an uncertainty associated with its calibration. The uncertainty may therefore be considered to be the variance of the vial content and was determined to be +/- 0.53 %.
核酸扩增技术甲型肝炎病毒VL国际标准品 CONTENTS Country of origin of biological material: South Africa. Each vial contains 0.5 mL of lyophilized plasma containing infectious HAV.
15/276 STABILITY Reference materials are held at NIBSC within assured, temperaturecontrolled storage facilities and they should be stored on receipt as indicated on the label. It is the policy of WHO not to assign an expiry date to their international reference materials. Accelerated degradation studies have indicated that this material is suitably stable, when stored at -20 ⁰C, for the assigned values to remain valid until the material is withdrawn or replaced. These studies have also shown that the material is suitably stable for shipment at ambient temperature without any effect on the assigned values. Users who have data supporting any deterioration in the characteristics of any reference preparation are encouraged to contact NIBSC.
